{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:14:58Z","timestamp":1788225298607,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.clinre.2026.102873","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:09Z","timestamp":1782432009000},"page":"102873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u20ac2.7 billion for the treatment of patients with pancreatic cancer: an overview and perspectives in France"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0454-5246","authenticated-orcid":false,"given":"Honorat","family":"Agb\u00e9ci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Castelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Coffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Piquemal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e9o","family":"Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Bachet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clinre.2026.102873_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.bulcan.2017.11.004","article-title":"\u00c9pid\u00e9miologie du cancer du pancr\u00e9as","volume":"105","author":"Drouillard","year":"2018","journal-title":"Bull Cancer"},{"issue":"21","key":"10.1016\/j.clinre.2026.102873_bib0002","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.3390\/cancers14215382","article-title":"Artificial intelligence-driven diagnosis of pancreatic cancer","volume":"14","author":"Hameed","year":"2022","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.clinre.2026.102873_bib0003","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyx088","article-title":"Focus on an unusual rise in pancreatic cancer incidence in France","volume":"46","author":"Bouvier","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.clinre.2026.102873_bib0004","series-title":"Projection de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine en 2015 [Rapport technique] [Internet]","first-page":"66","author":"Leone","year":"2015"},{"issue":"1","key":"10.1016\/j.clinre.2026.102873_bib0007","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2024-001544","article-title":"Current and projected incidence rates of pancreatic cancer in 43 countries: an analysis of the cancer incidence in five continents database","volume":"12","author":"Shou","year":"2025","journal-title":"BMJ Open Gastroenterol"},{"issue":"9\u201110","key":"10.1016\/j.clinre.2026.102873_bib0008","article-title":"More deaths from pancreatic cancer than breast cancer in the EU by 2017","volume":"55","author":"Ferlay","year":"2016","journal-title":"Acta Oncol"},{"issue":"11","key":"10.1016\/j.clinre.2026.102873_bib0009","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinre.2026.102873_bib0010","unstructured":"Les cancers du pancr\u00e9as. Fondation ARC [Internet]. [cit\u00e9 22 mai 2025]. Disponible sur: https:\/\/www.fondation-arc.org\/cancer\/cancer-pancreas."},{"issue":"11","key":"10.1016\/j.clinre.2026.102873_bib0011","article-title":"Exposure to environmental chemicals and heavy metals, and risk of pancreatic cancer","volume":"26","author":"Antwi","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clinre.2026.102873_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2017.08.035","article-title":"A systematic review of economic evaluation in pancreatic ductal adenocarcinoma","volume":"86","author":"G\u00e9rard","year":"2017","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.clinre.2026.102873_bib0013","doi-asserted-by":"crossref","DOI":"10.1080\/14796694.2024.2435253","article-title":"Real-world clinical outcomes and economic burden of metastatic pancreatic ductal adenocarcinoma: a systematic review","volume":"21","author":"Cockrum","year":"2025","journal-title":"Future Oncol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102873_bib0014","doi-asserted-by":"crossref","DOI":"10.3109\/0284186X.2012.744140","article-title":"Pancreatic cancer - cost for overtreatment with gemcitabine","volume":"52","author":"Ansari","year":"2013","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clinre.2026.102873_bib0015","doi-asserted-by":"crossref","DOI":"10.1177\/17588359241259635","article-title":"French multi-institutional cost-effectiveness analysis of gemcitabine plus nab-paclitaxel versus gemcitabine alone as second-line treatment in metastatic pancreatic cancer patients","volume":"16","author":"Demaziere","year":"2024","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.clinre.2026.102873_bib0016","unstructured":"Aster\u00e8s, Le co\u00fbt du cancer en France (\u00e9tude 2017). [Internet]. Disponible sur: https:\/\/asteres.fr\/site\/wp-content\/uploads\/2020\/02\/ASTERES-CANCER-FEV-2020-compresse.pdf."},{"issue":"18","key":"10.1016\/j.clinre.2026.102873_bib0017","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Hoff","year":"2013","journal-title":"New Engl J Med"},{"issue":"10018","key":"10.1016\/j.clinre.2026.102873_bib0018","doi-asserted-by":"crossref","first-page":"545\u201157","DOI":"10.1016\/S0140-6736(15)00986-1","article-title":"Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial","volume":"387","author":"Wang-Gillam","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clinre.2026.102873_bib0019","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance Olaparib for germline BRCA-mutated metastatic pancreatic cancer","author":"Golan","year":"2019","journal-title":"New Engl J Med"},{"issue":"11","key":"10.1016\/j.clinre.2026.102873_bib0020","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"8","key":"10.1016\/j.clinre.2026.102873_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2024.102426","article-title":"Nationwide trends over 10 years in epidemiology and management of pancreatic ductal adenocarcinoma: a real-world study from the French administrative database","volume":"48","author":"Mas","year":"2024","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.clinre.2026.102873_bib0022","unstructured":"INCa; Sant\u00e9 publique France H civils de L (Service de biostatistique). Estimations r\u00e9gionales et d\u00e9partementales de l\u2019incidence et de la mortalit\u00e9 par cancer en France, 2007-2016 \u2013 R\u00e9gion Pays de la Loire. Saint-Maurice; 2019. p. 84."},{"key":"10.1016\/j.clinre.2026.102873_bib0023","unstructured":"Les cancers en France, \u00e9dition 2017, Collection Les Donn\u00e9es, Institut national du cancer, avril 2018."},{"key":"10.1016\/j.clinre.2026.102873_bib0024","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 [Internet]. [cit\u00e9 30 ao\u00fbt 2025]. Choix m\u00e9thodologiques pour l\u2019analyse de l\u2019impact budg\u00e9taire \u00e0 la HAS. Disponible sur: https:\/\/www.has-sante.fr\/jcms\/c_2730306\/fr\/choix-methodologiques-pour-l-analyse-de-l-impact-budgetaire-a-la-has."},{"key":"10.1016\/j.clinre.2026.102873_bib0025","unstructured":"Haute Autorit\u00e9 de Sant\u00e9 [Internet]. [cit\u00e9 16 juill 2025]. Choix m\u00e9thodologiques pour l\u2019\u00e9valuation \u00e9conomique \u00e0 la HAS. Disponible sur: https:\/\/www.has-sante.fr\/jcms\/r_1499251\/fr\/choix-methodologiques-pour-l-evaluation-economique-a-la-has."},{"key":"10.1016\/j.clinre.2026.102873_bib0026","series-title":"R: a language and environment for statistical computing","year":"2013"},{"issue":"3","key":"10.1016\/j.clinre.2026.102873_bib0028","doi-asserted-by":"crossref","first-page":"314\u201123","DOI":"10.1038\/s41431-017-0081-3","article-title":"Cost of cancer diagnosis using next-generation sequencing targeted gene panels in routine practice: a nationwide French study","volume":"26","author":"Marino","year":"2018","journal-title":"Eur J Hum Genet"},{"issue":"5","key":"10.1016\/j.clinre.2026.102873_bib0029","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12032-016-0762-8","article-title":"Cost description of chemotherapy regimens for the treatment of metastatic pancreas cancer","volume":"33","author":"Goldstein","year":"2016","journal-title":"Med Oncol"},{"issue":"7","key":"10.1016\/j.clinre.2026.102873_bib0030","doi-asserted-by":"crossref","first-page":"1434\u201141","DOI":"10.1016\/j.pan.2020.09.002","article-title":"The economic burden of metastatic pancreatic cancer","volume":"20","author":"Malangone-Monaco","year":"2020","journal-title":"Pancreatol : Offic J Int Assoc Pancreatol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102873_bib0031","doi-asserted-by":"crossref","DOI":"10.1097\/01.sla.0000246856.03918.9a","article-title":"Assessment of complications after pancreatic surgery","volume":"244","author":"DeOliveira","year":"2006","journal-title":"Ann Surg"},{"issue":"20","key":"10.1016\/j.clinre.2026.102873_bib0032","article-title":"Costs and trends in pancreatic cancer treatment","volume":"118","author":"O\u2019Neill","year":"2012","journal-title":"Cancer"},{"issue":"49","key":"10.1016\/j.clinre.2026.102873_bib0033","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000018082","article-title":"Pancreatic cancer treatment costs, including patient liability, by phase of care and treatment modality, 2000\u20132013","volume":"98","author":"Tramontano","year":"2019","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.clinre.2026.102873_bib0034","doi-asserted-by":"crossref","first-page":"866\u201171","DOI":"10.1080\/0284186X.2021.1892821","article-title":"Projected economic burden of pancreatic cancer in Sweden in 2030","volume":"60","author":"Draus","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clinre.2026.102873_bib0035","doi-asserted-by":"crossref","first-page":"S917","DOI":"10.1016\/j.annonc.2023.09.2617","article-title":"1668P prevalence and management of pancreatic ductal adenocarcinoma (PDAC) over a decade in France: a population-based study","volume":"34","author":"Mas","year":"2023","journal-title":"Ann Oncol"},{"issue":"23","key":"10.1016\/j.clinre.2026.102873_bib0036","doi-asserted-by":"crossref","first-page":"2306\u201116","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.clinre.2026.102873_bib0037","doi-asserted-by":"crossref","first-page":"1702\u20119","DOI":"10.1016\/S1470-2045(19)30532-7","article-title":"Tumour Treating Fields in combination with pemetrexed and cisplatin or carboplatin as first-line treatment for unresectable malignant pleural mesothelioma (STELLAR): a multicentre, single-arm phase 2 trial","volume":"20","author":"Ceresoli","year":"2019","journal-title":"Lancet Oncol"},{"issue":"9","key":"10.1016\/j.clinre.2026.102873_bib0038","doi-asserted-by":"crossref","first-page":"1002\u201117","DOI":"10.1016\/S1470-2045(23)00344-3","article-title":"Tumor treating fields therapy with standard systemic therapy versus standard systemic therapy alone in metastatic non-small-cell lung cancer following progression on or after platinum-based therapy (LUNAR): a randomised, open-label, pivotal phase 3 study","volume":"24","author":"Leal","year":"2023","journal-title":"Lancet Oncol"},{"issue":"21","key":"10.1016\/j.clinre.2026.102873_bib0039","doi-asserted-by":"crossref","first-page":"2350\u201160","DOI":"10.1200\/JCO-25-00746","article-title":"Tumor treating fields with gemcitabine and nab-paclitaxel for locally advanced pancreatic adenocarcinoma: randomized, open-label, pivotal phase III PANOVA-3 study","volume":"43","author":"Babiker","year":"2025","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clinre.2026.102873_bib0040","doi-asserted-by":"crossref","first-page":"994\u20111017","DOI":"10.1158\/2159-8290.CD-24-0027","article-title":"Translational and therapeutic evaluation of RAS-GTP inhibition by RMC-6236 in RAS-driven cancers","volume":"14","author":"Jiang","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.clinre.2026.102873_bib0041","doi-asserted-by":"crossref","DOI":"10.1007\/s10198-025-01793-4","article-title":"Economic evaluations of early detection strategies for pancreatic cancer: a systematic review","author":"Wittram","year":"2025","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.clinre.2026.102873_bib0042","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13098-025-01750-4","article-title":"Targeting early diagnosis and treatment of pancreatic cancer among the diabetic population: a comprehensive review of biomarker screening strategies","volume":"17","author":"Yang","year":"2025","journal-title":"Diabetol Metab Syndrome"},{"issue":"2","key":"10.1016\/j.clinre.2026.102873_bib0043","doi-asserted-by":"crossref","first-page":"997\u20111007","DOI":"10.21037\/jgo-22-946","article-title":"Performance of a blood-based RNA signature for gemcitabine-based treatment in metastatic pancreatic adenocarcinoma","volume":"14","author":"Piquemal","year":"2023","journal-title":"J Gastrointest Oncol"},{"key":"10.1016\/j.clinre.2026.102873_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2025.102973","article-title":"Medical management of pancreatic cancer: from personalization to broadening treatment strategies","volume":"138","author":"Dusetti","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clinre.2026.102873_bib0045","doi-asserted-by":"crossref","first-page":"76\u201188","DOI":"10.1016\/j.semcancer.2025.02.009","article-title":"Biomarkers, omics and artificial intelligence for early detection of pancreatic cancer","volume":"111","author":"Murray","year":"2025","journal-title":"Sem Cancer Biol"},{"key":"10.1016\/j.clinre.2026.102873_bib0046","unstructured":"Liang T. Research of the Application of Artificial Intelligence Model 'PANDA': A MultiCenter, Prospective Randomized Controlled Clinical Trial [Clinical trial registration] [Internet]. clinicaltrials.gov; juill 2024 [cit\u00e9 24 juill 2025]. Clinical trial registration no.: NCT06528223. Disponible sur: https:\/\/clinicaltrials.gov\/study\/NCT06528223."},{"key":"10.1016\/j.clinre.2026.102873_bib0047","unstructured":"Liang T. Research of the Application of Pancreatic Cancer Screening Artificial Intelligence Model 'PANDA PLUS': A MultiCenter, Prospective Randomized Controlled Clinical Trial [Clinical trial registration] [Internet]. clinicaltrials.gov; avr 2025 [cit\u00e9 24 juill 2025]. Clinical trial registration no.: NCT06643715. Disponible sur: https:\/\/clinicaltrials.gov\/study\/NCT06643715."}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740126001191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:45:15Z","timestamp":1788223515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740126001191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":44,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2210740126001191"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102873","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u20ac2.7 billion for the treatment of patients with pancreatic cancer: an overview and perspectives in France","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2026.102873","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102873"}}